Ekso Bionics (EKSO) Addressable Market to Grow on CMS Update

Ekso Bionics (EKSO) has reached a significant milestone in terms of transforming mobility solutions, particularly for individuals with spinal cord injuries (SCI). The company recently secured initial reimbursement from the Centers for Medicare & Medicaid Services (CMS) for its Ekso Indego Personal exoskeleton. This achievement is poised to expand Ekso Bionics' foothold in the growing exoskeleton technology market, which is gaining traction in both medical and industrial sectors. Strategic Implications The C ...